Human platelet alpha granules contain a nonspecific inhibitor of megakaryocyte colony formation: its relationship to type beta transforming growth factor (TGF-beta).
Whole blood serum (WBS) and platelet-poor plasma-derived serum (PDS) from the same normal subject were compared for their abilities to support human megakaryocyte (MK) colony formation. In all cases, PDS promoted the growth of a higher number (20-50%) of MK colonies than did WBS. Increasing amounts of WBS decreased the number of colonies, whereas increasing concentration of PDS had no marked effects. Crude platelet extracts or platelet secretory products from thrombin-activated platelets also elicited an inhibition of MK colony formation in a dose-dependent manner. A complete inhibition was found for a dose equivalent to 1.10(9) platelets/ml and a 50% inhibition in a range of 1.10(7)-1.10(8) platelets/ml. These platelet products were also inhibitory for erythroid progenitor growth. Platelets from two patients with gray platelet syndrome elicited only a minor inhibition of MK growth, suggesting that the platelet alpha granule is the origin of this inhibition. When platelet extracts were acid-treated, the biological activity of the inhibitor on CFU-MK and CFU-E growth was 20-50-fold higher. In addition, a potent stimulatory activity on the growth of day 7 CFU-GM was observed. The enhancement of biological activities by acid treatment suggests that type beta transforming growth factor (TGF-beta) could be involved in this platelet inhibitory activity. The homogeneous native TGF-beta (from 1 pg to 1 ng/ml) produced the same effects previously induced by platelet products. It totally inhibited CFU-MK growth (at a 500 pg/ml), it inhibited CFU-E growth, and it stimulated growth of day 7 CFU-GM in the presence of a colony-stimulating factor. The inhibition of CFU-MK growth was also observed on purified progenitors. In conclusion, these results suggest that TGF-beta may be implicated in negative autocrine regulation of megakaryopoiesis. However, since this molecule has ubiquitous biological activities, its physiologic relevance as a normal regulator of megakaryopoiesis requires further investigation.
INSERM U 91, Hôpital Henri Mondor, Créteil, France.
M T
MT
Mitjavila
G
G
Vinci
J L
JL
Villeval
N
N
Kieffer
A
A
Henri
U
U
Testa
J
J
Breton-Gorius
W
W
Vainchenker
D001790:Blood Physiological Phenomena; D001792:Blood Platelets / Q000032:analysis / Q000378:metabolism / Q000502:physiology*; D002455:Cell Division / Q000187:drug effects; D003594:Cytoplasmic Granules / Q000378:metabolism / Q000502:physiology*; D004920:Erythropoiesis / Q000187:drug effects; D006801:Humans; D008533:Megakaryocytes / Q000166:cytology*; D010455:Peptides / Q000494:pharmacology*; D013234:Stem Cells / Q000166:cytology*; D014020:Tissue Extracts / Q000494:pharmacology; D015291:Transforming Growth Factors
D010455:Peptides; D014020:Tissue Extracts; D015291:Transforming Growth Factors